| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8630027 | Diabetes Research and Clinical Practice | 2018 | 18 Pages |
Abstract
In T2D patients with an HbA1c â§7%, a higher baseline dopHbA1c was associated with a greater HbA1c reduction after shifting to vildagliptin-based dual oral therapy.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Jun-Sing Wang, Yi-Jen Hung, Yung-Chuan Lu, Cheng-Lin Tsai, Wei-Shiung Yang, Ting-I Lee, Ya-Chun Hsiao, Wayne Huey-Herng Sheu,